F18-PSMA-1007 PET for early biochemical recurrence of prostate cancer, comparison with 18F-Fluciclovine. - F18-PSMA-1007 PET for early biochemical recurrence of prostate cancer.

Radboud Universitair Medisch Centrum0 个研究点目标入组 50 人待定

适应症Prostate carcinoma adenocarcinoma of the prostate 10038597

概览

阶段: 2 期
干预措施: 未指定
疾病 / 适应症: Prostate carcinoma
发起方: Radboud Universitair Medisch Centrum
入组人数: 50
状态: 已完成
最后更新: 2年前

概览研究者入排标准结局指标相似试验

概览

简要总结

暂无简介。

注册库

who.int

开始日期

待定

结束日期

待定

最后更新

2年前

研究类型

Interventional

研究者

发起方

Radboud Universitair Medisch Centrum

入排标准

入选标准

•\- Males \* 18 years
•\- Histologically proven adenocarcinoma of the prostate
•\- Prior local treatment with curative intent
•\- Biochemical recurrence with (rising) PSA\-levels of 0\.2\-5\.0 ug/L
•\- PSA level determined \<8 weeks before study participation

排除标准

•\- Contra\-indications for PET\-CT: claustrophobia or inability to lay still for the duration of the exam
•\- Other cancer \< 2 years prior to biochemical recurrence

结局指标

主要结局

未指定

相似试验

进行中（未招募）

1 期

F18-PSMA-1007 PET for early biochemical recurrence of prostate cancer.

EUCTR2018-001267-22-NLRadboud University Medical Center50

Unknown

不适用

F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate CancerProstate Cancer Recurrent

NCT04239742Radboud University Medical Center50

已完成

不适用

Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image FeaturesProstate Cancer

NCT06604377Ruijin Hospital203

已完成

3 期

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate CancerProstate CancerProstate Cancer Recurrent

NCT04742361ABX advanced biochemical compounds GmbH136

进行中（未招募）

1 期

18F-fluoride PET for Early Non-invasive Assessment of Cortical Bone Formation - Non-invasive Assessment of Cortical Bone Formation - Version 1

EUCTR2009-016523-61-GBKing’s College London30